Healthcare-associated infections in neonates

Current Opinion in Infectious Diseases

Volumn 21, Issue 3, 2008, Pages 228-234

  Zingg, Walter ^a   Posfay Barbe, Klara M ^a   Pittet, Didier ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Extended spectrum lactamase; Fluconazole prophylaxis; Infection control; Methicillin resistant Staphylococcus aureus; Neonatal care; Outbreaks

Indexed keywords

ANTIBIOTIC AGENT; CLINDAMYCIN; EXTENDED SPECTRUM BETA LACTAMASE; FLUCONAZOLE; IMMUNOGLOBULIN; PYRROLE DERIVATIVE; RIFAMPICIN;

ACINETOBACTER BAUMANNII; CANDIDIASIS; CLINICAL TRIAL; CONJUNCTIVITIS; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; ENDOPHTHALMITIS; HEALTH CARE; HUMAN; INFECTION RISK; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NEWBORN CARE; NEWBORN SEPSIS; PENICILLIN RESISTANCE; PRACTICE GUIDELINE; PREVALENCE; PROPHYLAXIS; REVIEW; SERRATIA MARCESCENS; STAPHYLOCOCCUS INFECTION; URINARY TRACT INFECTION; VENTILATOR ASSOCIATED PNEUMONIA;

ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; COMMUNICABLE DISEASES; CROSS INFECTION; DISEASE OUTBREAKS; FLUCONAZOLE; HUMANS; INFANT, NEWBORN; METHICILLIN RESISTANCE;

EID: 42949174617     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/QCO.0b013e3282fcec5f     Document Type: Review

References (90)

1. Stover BH, Shulman ST, Bratcher DF, et al. Nosocomial infection rates in US children's hospitals' neonatal and pediatric intensive care units. Am J Infect Control 2001; 29:152-157.
2. Hentschel J, Brungger B, Studi K, Muhlemann K. Prospective surveillance of nosocomial infections in a Swiss NICU: low risk of pneumonia on nasal continuous positive airway pressure? Infection 2005; 33:350-355.
3. Schwab F, Geffers C, Barwolff S, et al. Reducing neonatal nosocomial bloodstream infections through participation in a national surveillance system. J Hosp Infect 2007; 65:319-325. A national nosocomial surveillance for neonatal intensive care patients over 3 years in Germany (Krankenhaus-Infektions-Surveillance-System; KISS).
4. Contreras-Cuellar GA, Leal-Castro AL, Prieto R, Carvajal-Hermida AL. Device-associated infections in a Colombian neonatal intensive care unit. Rev Salud Publica (Bogota) 2007; 9:439-447.
5. El-Nawawy AA, Abd El-Fattah MM, Metwally HA, et al. One year study of bacterial and fungal nosocomial infections among patients in pediatric intensive care unit (PICU) in Alexandria. J Trop Pediatr 2006; 52:185-191.
6. Balkhy HH, Cunningham G, Chew FK, et al. Hospital- and communityacquired infections: a point prevalence and risk factors survey in a tertiary care center in Saudi Arabia. Int J Infect Dis 2006; 10:326-333.
7. Couto RC, Carvalho EA, Pedrosa TM, et al. A 10-year prospective surveillance of nosocomial infections in neonatal intensive care units. Am J Infect Control 2007; 35:183-189. A prospective cohort study among six Brazilian NICUs over 10 years.
8. Elward AM, Fraser VJ. Risk factors for nosocomial primary bloodstream infection in pediatric intensive care unit patients: a 2-year prospective cohort study. Infect Control Hosp Epidemiol 2006; 27:553-560.
9. Jaballah NB, Bouziri A, Mnif K, et al. Epidemiology of hospital-acquired bloodstream infections in a Tunisian pediatric intensive care unit: a 2-year prospective study. Am J Infect Control 2007; 35:613-618.
10. Mireya UA, Marti PO, Xavier KV, et al. Nosocomial infections in paediatric and neonatal intensive care units. J Infect 2007; 54:212-220.
11. Raka L, Zoutman D, Mulliqi G, et al. Prevalence of nosocomial infections in high-risk units in the University Clinical Center of Kosova. Infect Control Hosp Epidemiol 2006; 27:421-423.
12. Perlman SE, Saiman L, Larson EL. Risk factors for late-onset healthcare-associated bloodstream infections in patients in neonatal intensive care units. Am J Infect Control 2007; 35:177-182.
13. Buckley J, Coffin SE, Lautenbach E, et al. Outcome of Escherichia coli and/or Klebsiella bloodstream infection in children with central venous catheters. Infect Control Hosp Epidemiol 2007; 28:1308-1310.
14. Couto RC, Pedrosa TM, Tofani Cde P, Pedroso ER. Risk factors for nosocomial infection in a neonatal intensive care unit. Infect Control Hosp Epidemiol 2006; 27:571-575.
15. Tan LH, Hess B, Diaz LK, et al. Survey of the use of peripherally inserted central venous catheters in neonates with critical congenital cardiac disease. Cardiol Young 2007; 17:196-201.
16. Von Dolinger de Brito D, de Almeida Silva H, Jose Oliveira E, et al. Effect of neonatal intensive care unit environment on the incidence of hospital-acquired infection in neonates. J Hosp Infect 2007; 65:314-318.
17. Graham PL III, Della-Latta P, Wu F, et al. The gastrointestinal tract serves as the reservoir for Gram-negative pathogens in very low birth weight infants. Pediatr Infect Dis J 2007; 26:1153-1156.
18. Foglia E, Meier MD, Elward A. Ventilator-associated pneumonia in neonatal and pediatric intensive care unit patients. Clin Microbiol Rev 2007; 20:409-425. A comprehensive study about VAP among PICU and NICU patients.
19. Sastre JB, Aparicio AR, Cotallo GD, et al. Urinary tract infection in the newborn: clinical and radio imaging studies. Pediatr Nephrol 2007; 22:1735-1741. A study comparing the clinical characteristics and diagnostic findings of community-acquired and nosocomial UTI in newborns, suggesting that urinary catheters do not play a major role in the emergence of nosocomial infection.
20. Su BH, Hsieh HY, Chiu HY, Lin HC. Nosocomial infection in a neonatal intensive care unit: a prospective study in Taiwan. Am J Infect Control 2007; 35:190-195.
21. Salamati P, Rahbarimanesh AA, Yunesian M, Naseri M. Neonatal nosocomial infections in Bahrami Children Hospital. Indian J Pediatr 2006; 73:197-200.
22. Kagen J, Lautenbach E, Bilker WB, et al. Risk factors for mediastinitis following median sternotomy in children. Pediatr Infect Dis J 200; 26: 613-618.
23. Hayhurst C, Cooke R, Williams D, et al. The impact of antibiotic-impregnated catheters on shunt infection in children and neonates. Childs Nerv Syst 2007 [Epub ahead of print].
24. Haas J, Larson E, Ross B, et al. Epidemiology and diagnosis of hospital-acquired conjunctivitis among neonatal intensive care unit patients. Pediatr Infect Dis J 2005; 24:586-589.
25. Jeong IS, Jeong JS, Choi EO. Nosocomial infection in a newborn intensive care unit (NICU), South Korea. BMC Infect Dis 2006; 6:103.
26. Sparks JR, Recchia FM, Weitkamp JH. Endogenous group B streptococcal endophthalmitis in a preterm infant. J Perinatol 2007; 27:392-394.
27. Bizzarro MJ, Raskind C, Baltimore RS, Gallagher PG. Seventy-five years of neonatal sepsis at Yale: 1928-2003. Pediatrics 2005; 116:595-602.
28. Hira V, Sluijter M, Estevao S, et al. Clinical and molecular epidemiologic characteristics of coagulase-negative staphylococcal bloodstream infections in intensive care neonates. Pediatr Infect Dis J 2007; 26:607-612.
29. Apisarnthanarak A, Holzmann-Pazgal G, Hamvas A, et al. Ventilator-associated pneumonia in extremely preterm neonates in a neonatal intensive care unit: characteristics, risk factors, and outcomes. Pediatrics 2003; 112: 1283-1289.
30. Huang YC, Chou YH, Su LH, et al. Methicillin-resistant Staphylococcus aureus colonization and its association with infection among infants hospitalized in neonatal intensive care units. Pediatrics 2006; 118:469-474.
31. Gerber SI, Jones RC, Scott MV, et al. Management of outbreaks of methicillinresistant Staphylococcus aureus infection in the neonatal intensive care unit: a consensus statement. Infect Control Hosp Epidemiol 2006; 27: 139-145.
32. Ko KS, Park S, Peck KR, et al. Molecular characterization of methicillin-resistant Staphylococcus aureus spread by neonates transferred from primary obstetrics clinics to a tertiary care hospital in Korea. Infect Control Hosp Epidemiol 2006; 27:593-597.
33. Sax H, Posfay-Barbe K, Harbarth S, et al. Control of a cluster of communityassociated, methicillin-resistant Staphylococcus aureus in neonatology. J Hosp Infect 2006; 63:93-100.
34. Behari P, Englund J, Alcasid G, et al. Transmission of methicillin-resistant Staphylococcus aureus to preterm infants through breast milk. Infect Control Hosp Epidemiol 2004; 25:778-780.
35. Community-associated methicillin-resistant Staphylococcus aureus infection among healthy newborns: Chicago and Los Angeles County, 2004. MMWR Morb Mortal Wkly Rep 2006; 55:329-332.
36. Denniston S, Riordan FA. Staphylococcus aureus bacteraemia in children and neonates: a 10 year retrospective review. J Infect 2006; 53:387-393.
37. Fortunov RM, Hulten KG, Hammerman WA, et al. Evaluation and treatment of community-acquired Staphylococcus aureus infections in term and latepreterm previously healthy neonates. Pediatrics 2007; 120:937-945. A retrospective study about community-acquired S. aureus infections revealed high MRSA rates with possible implications on antibiotic choice.
38. Benjamin DK Jr, Stoll BJ, Fanaroff AA, et al. Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months. Pediatrics 2006; 117: 84-92.
39. Clerihew L, Lamagni TL, Brocklehurst P, McGuire W. Invasive fungal infection in very low birthweight infants: national prospective surveillance study. Arch Dis Child Fetal Neonatal Ed 2006; 91:F188-F192.
40. Clerihew L, Austin N, McGuire W. Prophylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infants. Cochrane Database Syst Rev 2007; (4):CD003850. A systematic study on the use of prophylactic systemic antifungal agents. Although efficient in the majority of trials, the findings should be interpreted with caution, since the incidence of invasive fungal infection was very high in some control groups, there was no significant effect on overall mortality rates and there is a need for further data on the effect on the emergence of organisms with antifungal resistance.
41. Farmaki E, Evdoridou J, Pouliou T, et al. Fungal colonization in the neonatal intensive care unit: risk factors, drug susceptibility, and association with invasive fungal infections. Am J Perinatol 2007; 24:127-135.
42. Zaoutis TE, Heydon K, Localio R, et al. Outcomes attributable to neonatal candidiasis. Clin Infect Dis 2007; 44:1187-1193. Estimation of attributable costs of systemic candidiasis in hospitalized neonates within the United States using the 2003 Kid's Inpatient Database from the Healthcare Cost and Utilization Project. Invasive candidiasis is associated with a significantly increased risk of death and excess hospital charges in ELBW neonates and with excess hospital stay and excess hospital charges in neonates with a birth weight of at least 1000 g.
43. Fridkin SK, Kaufman D, Edwards JR, et al. Changing incidence of Candida bloodstream infections among NICU patients in the United States: 1995-2004. Pediatrics 2006; 117:1680-1687.
44. Clerihew L, Lamagni TL, Brocklehurst P, McGuire W. Candida parapsilosis infection in very low birthweight infants. Arch Dis Child Fetal Neonatal Ed 2007; 92:F127-F129.
45. Khan ZU, Al-Sweih NA, Ahmad S, et al. Outbreak of fungemia among neonates caused by Candida haemulonii resistant to amphotericin B, itraconazole, and fluconazole. J Clin Microbiol 2007; 45:2025-2027.
46. Jain A, Mondal R. Prevalence and antimicrobial resistance pattern of extended spectrum beta-lactamase producing Klebsiella spp isolated from cases of neonatal septicaemia. Indian J Med Res 2007; 125:89-94.
47. Mammina C, Di Carlo P, Cipolla D, et al. Surveillance of multidrug-resistant gram-negative bacilli in a neonatal intensive care unit: prominent role of cross transmission. Am J Infect Control 2007; 35:222-230. A prospective surveillance study over 1 year in an Italian NICU revealing cross-transmission of multidrug resistant Gram-negative bacilli due to poor infection control measures.
48. Crivaro V, Bagattini M, Salza MF, et al. Risk factors for extended-spectrum beta-lactamase-producing Serratia marcescens and Klebsiella pneumoniae acquisition in a neonatal intensive care unit. J Hosp Infect 2007; 67:135-141.
49. Linkin DR, Fishman NO, Patel JB, et al. Risk factors for extended-spectrum beta-lactamase-producing Enterobacteriaceae in a neonatal intensive care unit. Infect Control Hosp Epidemiol 2004; 25:781-783.
50. Pessoa-Silva CL, Meurer Moreira B, Camara Almeida V, et al. Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit: risk factors for infection and colonization. J Hosp Infect 2003; 53:198-206.
51. Kristof K, Szabo D, Marsh JW, et al. Extended-spectrum beta-lactamase-producing Klebsiella spp. in a neonatal intensive care unit: risk factors for the infection and the dynamics of the molecular epidemiology. Eur J Clin Microbiol Infect Dis 2007; 26:563-570.
52. Fakioglu E, Queenan AM, Bush K, et al. Amp C beta-lactamase- producing Escherichia coli in neonatal meningitis: diagnostic and therapeutic challenge. J Perinatol 2006; 26:515-517.
53. Bizzarro MJ, Dembry LM, Baltimore RS, Gallagher PG. Case-control analysis of endemic Serratia marcescens bacteremia in a neonatal intensive care unit. Arch Dis Child Fetal Neonatal Ed 2007; 92:F120-F126.
54. Gillespie EE, Bradford J, Brett J, Kotsanas D. Serratia marcescens bacteremia: an indicator for outbreak management and heightened surveillance. J Perinat Med 2007; 35:227-231.
55. Gras-Le Guen C, Fournier S, Andre-Richet B, et al. Almond oil implicated in a Staphylococcus capitis outbreak in a neonatal intensive care unit. J Perinatol 2007; 27:713-717.
56. Occelli P, Blanie M, Sanchez R, et al. Outbreak of staphylococcal bullous impetigo in a maternity ward linked to an asymptomatic healthcare worker. J Hosp Infect 2007; 67:264-270.
57. Mean M, Mallaret MR, Andrini P, et al. A neonatal specialist with recurrent methicillin-resistant Staphylococcus aureus (MRSA) carriage implicated in the transmission of MRSA to newborns. Infect Control Hosp Epidemiol 2007; 28:625-628.
58. Bertin ML, Vinski J, Schmitt S, et al. Outbreak of methicillin-resistant Staphylococcus aureus colonization and infection in a neonatal intensive care unit epidemiologically linked to a healthcare worker with chronic otitis. Infect Control Hosp Epidemiol 2006; 27:581-585.
59. Bertini G, Nicoletti P, Scopetti F, et al. Staphylococcus aureus epidemic in a neonatal nursery: a strategy of infection control. Eur J Pediatr 2006; 165: 530-555.
60. Cimolai N. Ocular methicillin-resistant Staphylococcus aureus infections in a newborn intensive care cohort. Am J Ophthalmol 2006; 142:183-184.
61. McDonald JR, Carriker CM, et al. Methicillin-resistant Staphylococcus aureus outbreak in an intensive care nursery: potential for interinstitutional spread. Pediatr Infect Dis J 2007; 26:678-683. This investigation reports the successful management of an MRSA outbreak. Genotyping revealed inter-institutional transfer and highlights the importance of MRSA surveillance and better communication between hospitals.
62. Shenoy S, Hegde A, Dominic SR, et al. An outbreak of extended spectrum beta-lactamase producing Klebsiella pneumoniae in a neonatal intensive care unit. Indian J Pathol Microbiol 2007; 50:669-670.
63. Chan PC, Huang LM, Lin HC, et al. Control of an outbreak of pandrug-resistant Acinetobacter baumannii colonization and infection in a neonatal intensive care unit. Infect Control Hosp Epidemiol 2007; 28:423-429.
64. Perniola R, Faneschi ML, Manso E, et al. Rhodotorula mucilaginosa outbreak in neonatal intensive care unit: microbiological features, clinical presentation, and analysis of related variables. Eur J Clin Microbiol Infect Dis 2006; 25:193-196.
65. van Asbeck EC, Huang YC, Markham AN, et al. Candida parapsilosis fungemia in neonates: genotyping results suggest healthcare workers hands as source, and review of published studies. Mycopathologia 2007; 164:287-293.
66. Lee JK. Two outbreaks of Burkholderia cepacia nosocomial infection in a neonatal intensive care unit. J Paediatr Child Health 2008; 44:62-66.
67. Jhung MA, Sunenshine RH, Noble-Wang J, et al. A national outbreak of Ralstonia mannitolilytica associated with use of a contaminated oxygen-delivery device among pediatric patients. Pediatrics 2007; 119:1061-1068. This is an exemplary case-control study investigating an outbreak with Ralstonia spp. Risk analysis identified the implication of a device that delivers humidified, warmed oxygen via nasal cannula. As a consequence, the device was recalled later on.
68. Molina-Cabrillana J, Santana-Reyes C, Gonzalez-Garcia A, et al. Outbreak of Achromobacter xylosoxidans pseudobacteremia in a neonatal care unit related to contaminated chlorhexidine solution. Eur J Clin Microbiol Infect Dis 2007; 26:435-437.
69. Ray P, Sharma S, Agarwal RK, et al. First detection of G12 rotaviruses in newborns with neonatal rotavirus infection at All India Institute of Medical Sciences, New Delhi, India. J Clin Microbiol 2007; 45:3824-3827.
70. Kusuhara K, Saito M, Sasaki Y, et al. An echovirus type 18 outbreak in a neonatal intensive care unit. Eur J Pediatr 2007 [Epub ahead of print].
71. Bhambhani V, Abraham J, Sahni M, et al. Outbreak of Coxsackie B4 arthritis among newborns and staff of a neonatal unit. Trop Doct 2007; 37:188-189. Report of an outbreak with Coxsackie B4 virus among neonates and HCW causing arthritis in both children and adults due to contamination of a water tank.
72. Aly H, Herson V, Duncan A, et al. Is bloodstream infection preventable among premature infants? A tale of two cities. Pediatrics 2005; 115:1513-1518.
73. Lobo RD, Levin AS, Gomes LM, et al. Impact of an educational program and policy changes on decreasing catheter-associated bloodstream infections in a medical intensive care unit in Brazil. Am J Infect Control 2005; 33:83-87.
74. Pessoa-Silva CL, Hugonnet S, Pfister R, et al. Reduction of healthcare associated infection risk in neonates by successful hand hygiene promotion. Pediatrics 2007; 120:e382-e390. Successful intervention cohort study in a Swiss neonatal unit. Using a multimodal hand hygiene promotion campaign guided by the HCWs' perceptions of the risk of hand contamination with regular performance feedbacks resulted in sustained BSI reductions.
75. Connell TG, Rele M, Cowley D, et al. How reliable is a negative blood culture result? Volume of blood submitted for culture in routine practice in a children's hospital. Pediatrics 2007; 119:891-896. This study investigates the value of adequate submissions of blood culture tests in pediatrics.
76. Singh K, Gavin PJ, Vescio T, et al. Microbiologic surveillance using nasal cultures alone is sufficient for detection of methicillin-resistant Staphylococcus aureus isolates in neonates. J Clin Microbiol 2003; 41:2755-2757.
77. Kim YH, Chang SS, Kim YS, et al. Clinical outcomes in methicillin-resistant Staphylococcus aureus-colonized neonates in the neonatal intensive care unit. Neonatology 2007; 91:241-247. Prospective cohort study about colonization, decolonization and spontaneous carriage loss of MRSA in a South Korean NICU and the community.
78. Manzoni P, Stolfi I, Pugni L, et al. A multicenter, randomized trial of prophylactic fluconazole in preterm neonates. N Engl J Med 2007; 356:2483-2495. Prophylactic fluconazole is efficient in the prevention of invasive Candida infections in neonates according to this randomized Italian multicenter study.
79. McCrossan BA, McHenry E, O'Neill F, et al. Selective fluconazole prophylaxis in high-risk babies to reduce invasive fungal infection. Arch Dis Child Fetal Neonatal Ed 2007; 92:F454-F458.
80. Manzoni P, Arisio R, Mostert M, et al. Prophylactic fluconazole is effective in preventing fungal colonization and fungal systemic infections in preterm neonates: a single-center, 6-year, retrospective cohort study. Pediatrics 2006; 117:e22-e32.
81. Clerihew L, McGuire W. Antifungal prophylaxis for very-low-birth-weight infants: UK national survey. Arch Dis Child Fetal Neonatal Ed 2007 [Epub ahead of print].
82. Burwell LA, Kaufman D, Blakely J, et al. Antifungal prophylaxis to prevent neonatal candidiasis: a survey of perinatal physician practices. Pediatrics 2006; 118:e1019-e1026.
83. Inglis GD, Jardine LA, Davies MW. Prophylactic antibiotics to reduce morbidity and mortality in neonates with umbilical artery catheters. Cochrane Database Syst Rev 2007:CD004697. There is insufficient evidence to support or refute the use of prophylactic antibiotics when umbilical artery catheters are inserted in newborn infants according to this systematic review.
84. Inglis GD, Jardine LA, Davies MW. Prophylactic antibiotics to reduce morbidity and mortality in ventilated newborn infants. Cochrane Database Syst Rev 2007:CD004338. There is insufficient evidence to support or refute the use of prophylactic antibiotics when starting mechanical ventilation in newborn infants according to this systematic review.
85. DeJonge M, Burchfield D, Bloom B, et al. Clinical trial of safety and efficacy of INH-A21 for the prevention of nosocomial staphylococcal bloodstream infection in premature infants. J Pediatr 2007; 151:260-265.
86. Labenne M, Michaut F, Gouyon B, et al. A population-based observational study of restrictive guidelines for antibiotic therapy in early-onset neonatal infections. Pediatr Infect Dis J 2007; 26:593-599. The use of restrictive guidelines for antibiotic therapy in early-onset neonatal infections does not increase the risk of infectious relapse, but is shown to decrease the incidence of late-onset infection.
87. Gray JW. Surveillance of infection in neonatal intensive care units. Early Hum Dev 2007; 83:157-163. This study provides a good summary about infection surveillance programs in neonatal units.
88. Gravel D, Matlow A, Ofner-Agostini M, et al. A point prevalence survey of healthcare-associated infections in pediatric populations in major Canadian acute care hospitals. Am J Infect Control 2007; 35:157-162.
89. Hajdu A, Samodova OV, Carlsson TR, et al. A point prevalence survey of hospital-acquired infections and antimicrobial use in a paediatric hospital in north-western Russia. J Hosp Infect 2007; 66:378-384.
90. Haas JP, Mendonca EA, Ross B, et al. Use of computerized surveillance to detect nosocomial pneumonia in neonatal intensive care unit patients. Am J Infect Control 2005; 33:439-443.